or Try an Advanced Search...

    Histone Deacetylase Inhibitor Stocks List

    Symbol Grade Name % Change
    MEIP D MEI Pharma, Inc. -0.97
    SNDX F Syndax Pharmaceuticals, Inc. 0.64
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Clinical Medicine Medicine Solid Tumors Antineoplastic Drugs Benzamides Breast Cancer Cancer Cell Cancer Therapies Clinical Development Hematological Malignancies Lung Cancer National Cancer Institute Novogen Pyridines Refractory Solid Tumors Treatment Of Breast Cancer Treatment Of Cancer Virotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Histone Deacetylase Inhibitor stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 1.37
    SURI A Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 1.1
    SBIO B ALPS Medical Breakthroughs ETF 1.07
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.72
    XBI B SPDR S&P Biotech ETF 0.49
    View all Histone Deacetylase Inhibitor ETFs...
    Compare ETFs
    Compare BBC to XBI Compare SURI to BBC Compare SURI to SBIO

        Histone Deacetylase Inhibitor Stocks Recent News

        Date Stock Title
        Nov 1 SNDX Syndax Announces Participation in November Investor Conferences
        Oct 29 SNDX Syndax to Announce Third Quarter 2024 Financial Results and Host Conference Call and Webcast on November 5, 2024
        Oct 28 MEIP MEI Pharma stock jumps 8% on sale of drug asset ME-344
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Clinical Medicine Medicine Solid Tumors Antineoplastic Drugs Benzamides Breast Cancer Cancer Cell Cancer Therapies Clinical Development Hematological Malignancies Lung Cancer National Cancer Institute Novogen Pyridines Refractory Solid Tumors Treatment Of Breast Cancer Treatment Of Cancer Virotherapy
        Histone Deacetylase Inhibitor

        Histone deacetylase inhibitors (HDAC inhibitors) are a class of drugs that inhibit the activity of histone deacetylases, enzymes that modify the structure of chromatin by removing acetyl groups from histones. HDAC inhibitors are used to treat a variety of diseases, including cancer, and have been studied as potential treatments for neurodegenerative diseases.

        Browse All Tags